![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Shandong Anxin Pharmaceutical Co., Ltd. Dongjia Town Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Olmesartan medoxomil, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-225 - Rev 00
This Chemical Type CEP, issued on January 05, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2600 associated with this CEP further emphasizes